Open access · CC-BY
via OpenAlex
The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial
Dominique E. Martin, Andreia N. Cadar, Hunter A. Panier, Blake L. Torrance, George A. Kuchel, Jenna M. Bartley
Immunity & Ageing · 2023 · ▲ 24 citations
Abstract
BACKGROUND: Aging is associated with progressive declines in immune responses leading to increased risk of severe infection and diminished vaccination responses. Influenza (flu) is a leading killer of older adults despite availability of seasonal vaccines. Geroscience-guided interventions targeting biological aging could offer transformational approaches to reverse broad declines in immune responses with aging. Here, we evaluated effects of metformin, an FDA approved diabetes drug and candidate anti-aging drug, on flu vaccination responses and markers of immunological resilience in a pilot and feasibility double-blinded placebo-controlled study. RESULTS: Healthy older adults (non-diabetic/non-prediabetic, age: 74.4 ± 1.7 years) were randomized to metformin (n = 8, 1500 mg extended release/daily) or placebo (n = 7) treatment for 20 weeks and were vaccinated with high-dose flu vaccine after 10 weeks of treatment. Peripheral blood mononuclear cells (PBMCs), serum, and plasma were collected prior to treatment, immediately prior to vaccination, and 1, 5, and 10 weeks post vaccination. Increased serum antibody titers were observed post vaccination with no significant differences between groups. Metformin treatment led to trending increases in circulating T follicular helper cells post-vaccination. Furthermore, 20 weeks of metformin treatment reduced expression of exhaustion marker CD57 in circulating CD4 T cells. CONCLUSIONS: Pre-vaccination metformin treatment improved some components of flu vaccine responses and reduced some markers of T cell exhaustion without serious adverse events in nondiabetic older adults. Thus, our findings highlight the potential utility of metformin to improve flu vaccine responses and reduce age-related immune exhaustion in older adults, providing improved immunological resilience in nondiabetic older adults.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12979-023-00343-x
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Martin, D.E., Cadar, A.N., Panier, H.A., Torrance, B.L., Kuchel, G.A., & Bartley, J.M. (2023). The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial. <em>Immunity & Ageing</em>. https://doi.org/10.1186/s12979-023-00343-x
Vancouver
Martin DE, Cadar AN, Panier HA, Torrance BL, Kuchel GA, Bartley JM. The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial. Immunity & Ageing. 2023. doi:10.1186/s12979-023-00343-x.
BibTeX
@article{dominique2023Theeff,
title = {The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial},
author = {Dominique E. Martin and Andreia N. Cadar and Hunter A. Panier and Blake L. Torrance and George A. Kuchel and Jenna M. Bartley},
journal = {Immunity & Ageing},
year = {2023},
doi = {10.1186/s12979-023-00343-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
UConn Health 2019
Open access · US-GOV
Vaccination Efficacy With Metformin in Older Adults: A Pilot Study
Immunity & Ageing 2023
Open access · CC-BY
Targeting the hallmarks of aging to improve influenza vaccine responses in older adults
Aging Cell 2025
Open access · CC-BY
Senolytic Treatment With Dasatinib and Quercetin Reshapes Influenza‐Specific CD8 T Cell Responses During Infection in Aged, Vaccinated Mice
Research Square 2025
Preprint · CC-BY
Spermidine Mitigates Immune Cell Senescence, Enhances Autophagy, and Boosts Vaccine Responses in Healthy Older Adults.
Frontiers in Aging 2026
Open access · CC-BY
The effect of metformin treatment during primary influenza infection on heterologous challenge in young and aged mice
Frontiers in aging 2026
Open access · OA